Pfizer (PFE) Aims $15 billion from COVID-19 vaccines sales in 2021
Pfizer (PFE) stock declined slightly despite a strong earnings report on Tuesday as investors focused on the company’s quarterly results. PFE stock performance year-to-date stands at -4.94%, while its performance over the last seven days is just below -6.22%. For the past month, the stock’s price index fell by -4.94%, and over the previous three-month […]
AstraZeneca plc (AZN) Welcomes European Green Light For Its Coronavirus Vaccine
Coronavirus vaccine developed by AstraZeneca plc (NASDAQ: AZN) and Oxford University have been approved by the European Medicines Agency for people aged 18 and over. Particularly, the European Medicines Agency (EMA) suggests that the AstraZeneca vaccine against coronavirus has been evaluated as safe and effective, and unanimously recommends its conditional approval by the European Commission. […]
